(Q44773047)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978453%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

title

Beyond control of acute exacerbation: enhancing affective and cognitive outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978453%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Herbert Y Meltzer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978453%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978453%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978453%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978453%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

11 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978453%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

16-8, 22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978453%20AND%20SRC:MED&resulttype=core&format=json

The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Interventions for neurocognitive deficits: editor's introduction

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Is it possible to be schizophrenic yet neuropsychologically normal?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

The role of cognition in vocational functioning in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Treatment-resistant schizophrenia--the role of clozapine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Novel antipsychotics and negative symptoms

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900008142

7 January 2021

10.1017/S1092852900008142

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14978453%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference